Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
The efficiency of paraformaldehyde (PFA) and binary ethylenimine (BEI) in inactivating recombinant vaccinia virus (rVV), present in baby hamster kidney cells expressing simian immunodeficiency virus envelope glycoproteins (SIV-Env), was measured in a series of inactivation studies. Both compounds were shown to be effective in reducing rVV titres. The use of standard 3-day titration assays proved to be inadequate to measure PFA inactivation, since upon prolonged incubation, residual rVV infectivity was detected in cultures negative at 3 days. Different procedures using PFA or BEI were selected to assess their influence on the antigenicity and immunogenicity or rVV expressed SIV-Env. Antigenicity, as defined by the ability to react with a panel of monoclonal antibodies recognizing major antigenic sites, and immunogenicity, as defined by the ability to induce SIV envelope specific and virus neutralizing serum antibodies in rats, proved to be preserved after either inactivation procedure. These data show that both protocols using PFA or BEI can be used successfully as part of the procedures to remove residual rVV infectivity.
Hulskotte
E G
EG
Institute of Virology, Erasmus University Rotterdam, The Netherlands.
Dings
M E
ME
Norley
S G
SG
Osterhaus
A D
AD
D000818:Animals; D001388:Aziridines / Q000494:pharmacology*; D006224:Cricetinae; D005404:Fixatives / Q000494:pharmacology*; D005557:Formaldehyde / Q000494:pharmacology*; D015686:Gene Products, env / Q000276:immunology*; D011108:Polymers / Q000494:pharmacology*; D051381:Rats; D015302:Simian Immunodeficiency Virus / Q000187:drug effects / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D014616:Vaccinia virus / Q000187:drug effects / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D001388:Aziridines; D005404:Fixatives; D015686:Gene Products, env; D011108:Polymers; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D005557:Formaldehyde; C033132:aziridine; C003043:paraform